These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human leptospirosis: In search for a better vaccine. Azevedo IR; Amamura TA; Isaac L Scand J Immunol; 2023 Nov; 98(5):e13316. PubMed ID: 39008520 [TBL] [Abstract][Full Text] [Related]
3. LigB subunit vaccine confers sterile immunity against challenge in the hamster model of leptospirosis. Conrad NL; Cruz McBride FW; Souza JD; Silveira MM; Félix S; Mendonça KS; Santos CS; Athanazio DA; Medeiros MA; Reis MG; Dellagostin OA; McBride AJ PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005441. PubMed ID: 28301479 [TBL] [Abstract][Full Text] [Related]
4. Human leptospirosis vaccines in China. Xu Y; Ye Q Hum Vaccin Immunother; 2018 Apr; 14(4):984-993. PubMed ID: 29148958 [TBL] [Abstract][Full Text] [Related]
5. Recombinant vaccines against leptospirosis. Dellagostin OA; Grassmann AA; Hartwig DD; Félix SR; da Silva ÉF; McBride AJ Hum Vaccin; 2011 Nov; 7(11):1215-24. PubMed ID: 22048111 [TBL] [Abstract][Full Text] [Related]
6. New strategies for Leptospira vaccine development based on LPS removal. Lauretti-Ferreira F; Silva PLD; Alcântara NM; Silva BF; Grabher I; Souza GO; Nakajima E; Akamatsu MA; Vasconcellos SA; Abreu PAE; Carvalho E; Martins EAL; Ho PL; da Silva JB PLoS One; 2020; 15(3):e0230460. PubMed ID: 32218590 [TBL] [Abstract][Full Text] [Related]
7. Antigenic potential of a recombinant polyvalent DNA vaccine against pathogenic leptospiral infection. Garba B; Bahaman AR; Zakaria Z; Bejo SK; Mutalib AR; Bande F; Suleiman N Microb Pathog; 2018 Nov; 124():136-144. PubMed ID: 30138761 [TBL] [Abstract][Full Text] [Related]
8. Large-scale application of highly-diluted bacteria for Leptospirosis epidemic control. Bracho G; Varela E; Fernández R; Ordaz B; Marzoa N; Menéndez J; García L; Gilling E; Leyva R; Rufín R; de la Torre R; Solis RL; Batista N; Borrero R; Campa C Homeopathy; 2010 Jul; 99(3):156-66. PubMed ID: 20674839 [TBL] [Abstract][Full Text] [Related]
9. DNA vaccines against leptospirosis: A literature review. Silveira MM; Oliveira TL; Schuch RA; McBride AJA; Dellagostin OA; Hartwig DD Vaccine; 2017 Oct; 35(42):5559-5567. PubMed ID: 28882437 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of a new octavalent combined Erysipelas, Parvo and Leptospira vaccine in gilts against Leptospira interrogans serovar Pomona associated disease and foetal death. Jacobs AA; Harks F; Hoeijmakers M; Collell M; Segers RP Vaccine; 2015 Jul; 33(32):3963-9. PubMed ID: 26100922 [TBL] [Abstract][Full Text] [Related]
11. Bovine Immune Response to Vaccination and Infection with Leptospira borgpetersenii Serovar Hardjo. Wilson-Welder JH; Alt DP; Nally JE; Olsen SC mSphere; 2021 Mar; 6(2):. PubMed ID: 33762318 [TBL] [Abstract][Full Text] [Related]
12. Leptospirosis is an emerging infectious disease of pig-hunting dogs and humans in North Queensland. Orr B; Westman ME; Malik R; Purdie A; Craig SB; Norris JM PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010100. PubMed ID: 35041681 [TBL] [Abstract][Full Text] [Related]
13. Estimation of the burden of leptospirosis in New Zealand. Sanhueza JM; Baker MG; Benschop J; Collins-Emerson JM; Wilson PR; Heuer C Zoonoses Public Health; 2020 Mar; 67(2):167-176. PubMed ID: 31799801 [TBL] [Abstract][Full Text] [Related]
15. A Leptospira borgpetersenii serovar Hardjo vaccine induces a Th1 response, activates NK cells, and reduces renal colonization. Zuerner RL; Alt DP; Palmer MV; Thacker TC; Olsen SC Clin Vaccine Immunol; 2011 Apr; 18(4):684-91. PubMed ID: 21288995 [TBL] [Abstract][Full Text] [Related]
16. Anti-Leptospira immunoglobulin profiling in mice reveals strain specific IgG and persistent IgM responses associated with virulence and renal colonization. Vernel-Pauillac F; Murray GL; Adler B; Boneca IG; Werts C PLoS Negl Trop Dis; 2021 Mar; 15(3):e0008970. PubMed ID: 33705392 [TBL] [Abstract][Full Text] [Related]
17. Leptospira and leptospirosis. Adler B; de la Peña Moctezuma A Vet Microbiol; 2010 Jan; 140(3-4):287-96. PubMed ID: 19345023 [TBL] [Abstract][Full Text] [Related]
18. [The evaluation of the reactogenicity and immunogenic activity of a new concentrated inactivated leptospirosis vaccine]. Ikoev VN; Gorbunov MA; Vachaev BF; Iagovkin EA; Kondratenko VF; Anan'ina IuV; Ansimova TI; Kostina NI; Iur'eva IL; Nikitin MG Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):39-43. PubMed ID: 10852048 [TBL] [Abstract][Full Text] [Related]
19. Onset and duration of protective immunity against clinical disease and renal carriage in dogs provided by a bi-valent inactivated leptospirosis vaccine. Minke JM; Bey R; Tronel JP; Latour S; Colombet G; Yvorel J; Cariou C; Guiot AL; Cozette V; Guigal PM Vet Microbiol; 2009 May; 137(1-2):137-45. PubMed ID: 19179023 [TBL] [Abstract][Full Text] [Related]
20. Investigation and response to an outbreak of leptospirosis among raspberry workers in Australia, 2018. Katelaris AL; Glasgow K; Lawrence K; Corben P; Zheng A; Sumithra S; Turahui J; Terry J; van den Berg D; Hennessy D; Kane S; Craig SB; Heading E; Burns MA; Corner HL; Sheppeard V; McAnulty J Zoonoses Public Health; 2020 Feb; 67(1):35-43. PubMed ID: 31550083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]